See more : Onamba Co., Ltd. (ONMBF) Income Statement Analysis – Financial Results
Complete financial analysis of Outset Medical, Inc. (OM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Outset Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- FPX Nickel Corp. (FPOCF) Income Statement Analysis – Financial Results
- InsCorp, Inc. (IBTN) Income Statement Analysis – Financial Results
- Xebio Holdings Co., Ltd. (8281.T) Income Statement Analysis – Financial Results
- Rogue Baron Plc (SHNJF) Income Statement Analysis – Financial Results
- Fintech Acquisition Corp. V (FTCV) Income Statement Analysis – Financial Results
Outset Medical, Inc. (OM)
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 130.38M | 115.38M | 102.60M | 49.94M | 15.08M | 2.01M |
| Cost of Revenue | 101.38M | 97.54M | 94.99M | 62.97M | 32.88M | 8.12M |
| Gross Profit | 29.00M | 17.83M | 7.61M | -13.04M | -17.80M | -6.12M |
| Gross Profit Ratio | 22.24% | 15.46% | 7.42% | -26.11% | -118.07% | -304.68% |
| Research & Development | 57.31M | 48.86M | 36.74M | 28.85M | 23.33M | 22.92M |
| General & Administrative | 45.23M | 40.52M | 36.32M | 30.51M | 8.92M | 6.25M |
| Selling & Marketing | 96.23M | 89.48M | 65.07M | 45.07M | 20.26M | 11.28M |
| SG&A | 141.46M | 130.00M | 101.39M | 75.58M | 29.18M | 17.53M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 198.77M | 178.85M | 138.13M | 104.43M | 52.51M | 40.45M |
| Cost & Expenses | 300.15M | 276.39M | 233.12M | 167.40M | 85.39M | 48.57M |
| Interest Income | 10.17M | 3.29M | 498.00K | 526.00K | 2.49M | 1.71M |
| Interest Expense | 12.68M | 3.57M | 1.72M | 2.37M | 4.26M | 4.64M |
| Depreciation & Amortization | 5.81M | 6.28M | 6.18M | 3.76M | 1.94M | 1.49M |
| EBITDA | -153.79M | -152.81M | -124.86M | -114.85M | -62.09M | -43.62M |
| EBITDA Ratio | -117.96% | -136.71% | -126.72% | -235.24% | -436.97% | -2,181.61% |
| Operating Income | -169.77M | -161.02M | -130.52M | -117.47M | -70.31M | -46.56M |
| Operating Income Ratio | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | -2,320.03% |
| Total Other Income/Expenses | -2.50M | -1.64M | -1.22M | -4.03M | 2.03M | -3.19M |
| Income Before Tax | -172.27M | -162.66M | -131.74M | -121.49M | -68.28M | -49.76M |
| Income Before Tax Ratio | -132.14% | -140.98% | -128.40% | -243.30% | -452.84% | -2,479.07% |
| Income Tax Expense | 523.00K | 295.00K | 199.00K | -794.00K | 20.00K | 25.00K |
| Net Income | -172.80M | -162.96M | -131.94M | -120.70M | -68.30M | -49.78M |
| Net Income Ratio | -132.54% | -141.24% | -128.59% | -241.71% | -452.97% | -2,480.32% |
| EPS | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| EPS Diluted | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| Weighted Avg Shares Out | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
| Weighted Avg Shares Out (Dil) | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Oct. 22, 2024 /PRNewswire/ -- Law Offices of Howard G.
Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM)
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OM Deadline: OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit
NEW YORK , Oct. 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the "Class...
Class Action Filed Against Outset Medical, Inc. (OM) - October 28, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
October 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against OM
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OM FINAL DEADLINE: RLF, A GLOBAL AND LEADING LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the...
Class Action Filed Against Outset Medical, Inc. (OM) - October 28, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OM
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Source: https://incomestatements.info
Category: Stock Reports